Dr. Justin Sanchez explains to host Dr. Larry Kaskel the latest research regarding neuroprosthetics. These prosthetics directly interface and decode brain communications. The greatest development arises in utilizing smart prosthetics called "brain chips" that learn with the patient overtime, and someday may be used routinely to help paralyzed patients control prosthetic limbs with their thoughts. Dr. Sanchez outlines the underlying mechanisms of these devices and the current research within humans. Tune in to hear how these brain-machine interfaces are being used to control prosthetics, and the potential applications to cure diseases such as epilepsy, addiction and Alzheimer's.
A Pacemaker for the Brain? Developments in Neuroprosthetics
Restart
Resume
Share this program on:
Choose a format
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Details
Presenters
Recommended
Details
Presenters
Overview
Dr. Justin Sanchez explains to host Dr. Larry Kaskel the latest research regarding neuroprosthetics. These prosthetics directly interface and decode brain communications. The greatest development arises in utilizing smart prosthetics called "brain chips" that learn with the patient overtime, and someday may be used routinely to help paralyzed patients control prosthetic limbs with their thoughts. Dr. Sanchez outlines the underlying mechanisms of these devices and the current research within humans. Tune in to hear how these brain-machine interfaces are being used to control prosthetics, and the potential applications to cure diseases such as epilepsy, addiction and Alzheimer's.
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Cardiology
Phase 3 study results of plozasiran in patients with FCS
<p>Phase 3 study results of plozasiran in patients with FCS</p>
CME/CE
Evolutions in Duchenne Muscular Dystrophy: Treatment Implications for the Present and Future
1.00 credits
<p>Evolutions in Duchenne Muscular Dystrophy: Treatment Implications for the Present and Future</p>
CME/CE
IgG4-RD Case Conversations: Retroperitoneal Fibrosis with Refractory Ureteral Involvement
0.50 credits
<p>IgG4-RD Case Conversations: Retroperitoneal Fibrosis with Refractory Ureteral Involvement</p>
MinuteCE®
Level Up Your Skills: Tailoring Management of HF
0.75 credits
<p>Level Up Your Skills: Tailoring Management of HF</p>
Cardiology
Effect of Finerenone on NT-proBNP in HFmrEF/HFpEF: FINEARTS-HF Trial
<p>Effect of Finerenone on NT-proBNP in HFmrEF/HFpEF: FINEARTS-HF Trial </p>
Cardiology
Kidney Risk Stratification in Finerenone Treatment: FINEARTS-HF Trial
<p>Kidney Risk Stratification in Finerenone Treatment: FINEARTS-HF Trial</p>
Cardiology
NYHA FC and Finerenone Response: Clinical Trial Insights
<p><span data-contrast="auto" xml:lang="EN-US">NYHA FC and Finerenone Response: Clinical Trial Insights</span><span data-ccp-props='{"134245417":false,"335559739":0}'> </span></p>
ACC Action Center
Semaglutide improves walking distance, symptoms and QoL in patients with PAD and T2D
<p>Semaglutide improves walking distance, symptoms and QoL in patients with PAD and T2D</p>
Register
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?